2016
DOI: 10.3109/14397595.2016.1158766
|View full text |Cite|
|
Sign up to set email alerts
|

One-year maintenance with routine assessment of patient index data 3-based remission may inhibit radiographic progression in patients with rheumatoid arthritis treated with routine clinical therapy: A retrospective comparison of radiographic outcome and its prognostic factors between maintained remissions with patient-reported outcome index and physician-oriented disease activity indices

Abstract: One-year RAPID3 remission maintenance may predict good radiographic outcomes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…Readers were blind to other clinical information. Reproducibility of the scoring for each reader has been guaranteed by previous articles with radiographic scoring assessment by the same experienced readers [16,18,20].…”
Section: Radiographic Acquisition and Visual Scoring Assessmentmentioning
confidence: 99%
“…Readers were blind to other clinical information. Reproducibility of the scoring for each reader has been guaranteed by previous articles with radiographic scoring assessment by the same experienced readers [16,18,20].…”
Section: Radiographic Acquisition and Visual Scoring Assessmentmentioning
confidence: 99%
“…Although effect sizes are variable across studies, RAPID3 categories generally demonstrate fair agreement with other validated composite disease activity measures as well as EULAR response categories (11,55,124,127,128). Sustained RAPID3 remission has been associated with significantly reduced radiographic progression (129). In a randomized controlled trial (RCT) comparing management based on the RAPID3 versus the CDAI, fewer responders were identified by the RAPID3 at week 12, but management by both measures led to a similar number achieving DAS28‐ESR low disease activity at 52 weeks (130).…”
Section: Routine Assessment Of Patient Activity Index (Rapid3 Rapid4mentioning
confidence: 99%